Remimazolam Approval Status
FDA Approved: No
Generic name: remimazolam
Company: Cosmo Pharmaceuticals NV
Treatment for: Anesthesia
Remimazolam is an ultra-short-acting intravenous benzodiazepine sedative/anesthetic in development for use during gastrointestinal procedures.
Development Status and FDA Approval Process for remimazolam
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.